Polypeptide

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

BioSeek Licenses Two Novel Anti-Inflammatory Peptides

Published December 3, 2008, 10:04 pm, DrugDiscoveryOnline

BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that it has exclusively licensed two novel anti-inflammatory peptides from Amylin Pharmaceuticals, Inc. The two novel peptides were identified as candidates for development by BioSeek as a result of an ongoing joint research collaboration initiated between the two companies in 2007. These ...

Discover News | Full Story


Learn about the Protein Therapeutics Markets (Antithrobins, Cytokines, Growth Hormones, Hematopoietics, Insulin, ...

Published December 2, 2008, 6:25 am, Business Wire via Yahoo! Finance

NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

Discover News | Full Story


TransMolecular Reaches Special Protocol Agreement with FDA for an 131I-TM601 Phase 3 Trial in Newly Diagnosed ...

Published December 2, 2008, 5:49 am, Centre Daily Times

TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under the FDA’s Special Protocol Assessment (SPA) process for a Phase 3 trial of 131 I-TM601 in patients with newly diagnosed Glioblastoma Multiforme (GBM). Through the SPA, the FDA has agreed that if the 131 ...

Discover News | Full Story


TransMolecular Reaches Special Protocol Agreement with FDA for an 131I-TM601 Phase 3 Trial in Newly Diagnosed ...

Published December 2, 2008, 5:02 am, Business Wire via Yahoo! Finance

CAMBRIDGE, Mass.----TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that it has reached an agreement with the U.S. Food and Drug Administration under the FDA’s Special Protocol Assessment process for a Phase 3 trial of 131I-TM601 in patients with newly diagnosed Glioblastoma Multiforme .

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a